Published in Prev Med on August 01, 2005
Adolescents' expectancies for smoking to regulate affect predict smoking behavior and nicotine dependence over time. Drug Alcohol Depend (2010) 1.12
Adverse childhood experiences and substance use among Hispanic emerging adults in Southern California. Addict Behav (2015) 0.89
Smoking determinants in Turkish university students. Int J Environ Res Public Health (2009) 0.86
Modeling mood variation and covariation among adolescent smokers: application of a bivariate location-scale mixed-effects model. Nicotine Tob Res (2013) 0.86
Self-efficacy mediates the effect of depression on smoking susceptibility in adolescents. Nicotine Tob Res (2011) 0.85
The mediating sex-specific effect of psychological distress on the relationship between adverse childhood experiences and current smoking among adults. Subst Abuse Treat Prev Policy (2012) 0.85
Cigarette smoking status and recurrent subjective health complaints among US school-aged adolescents. Child Care Health Dev (2010) 0.83
Affective motives for smoking among early stage smokers. Nicotine Tob Res (2014) 0.79
The roles of sex, anxious reactivity to bodily arousal, and anxiety sensitivity in coping motives for cigarette smoking among adolescents. Exp Clin Psychopharmacol (2016) 0.75
Measuring nicotine intake among highly-dependent adolescent smokers: comparability of saliva and plasma cotinine concentrations. Pharmacol Biochem Behav (2007) 0.75
Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nat Biotechnol (2010) 18.44
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature (2002) 9.62
Risperidone in children with autism and serious behavioral problems. N Engl J Med (2002) 9.35
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science (2005) 9.04
Integrative analysis of the melanoma transcriptome. Genome Res (2010) 8.46
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proc Natl Acad Sci U S A (2004) 5.15
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. J Virol (2003) 4.49
Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science (2007) 4.35
Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2. Dev Cell (2011) 3.12
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. Proc Natl Acad Sci U S A (2002) 3.08
A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol Cell (2012) 3.04
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest (2009) 2.82
Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study. Am J Psychiatry (2014) 2.81
Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network. Am J Psychiatry (2009) 2.44
Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth. Structure (2005) 2.09
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry (2010) 1.99
The anatomy of successful computational biology software. Nat Biotechnol (2013) 1.68
Better practices for youth tobacco cessation: evidence of review panel. Am J Health Behav (2003) 1.66
Smoking cessation treatment in community-based substance abuse rehabilitation programs. J Subst Abuse Treat (2007) 1.57
Morphology of anterior cruciate ligament attachments for anatomic reconstruction: a cadaveric dissection and radiographic study. Arthroscopy (2006) 1.55
ISAG/IUIS-VIC Comparative MHC Nomenclature Committee report, 2005. Immunogenetics (2006) 1.52
Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. Hum Antibodies (2005) 1.46
Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors. Retrovirology (2008) 1.37
Nomenclature report on the major histocompatibility complex genes and alleles of Great Ape, Old and New World monkey species. Immunogenetics (2012) 1.23
Tibiofemoral kinematics of the anterior cruciate ligament (ACL)-deficient weightbearing, living knee employing vertical access open "interventional" multiple resonance imaging. Am J Sports Med (2004) 1.23
Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody. J Virol (2005) 1.19
Improving the future of youth smoking cessation. Am J Health Behav (2003) 1.19
Using navigation to measure rotation kinematics during ACL reconstruction. Clin Orthop Relat Res (2007) 1.19
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res (2011) 1.17
A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection. J Virol (2010) 1.17
Review of safety assessment methods used in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (2003) 1.13
Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events. J Virol (2006) 1.12
How can we improve the assessment of safety in child and adolescent psychopharmacology? J Am Acad Child Adolesc Psychiatry (2003) 1.12
An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120. AIDS Res Hum Retroviruses (2004) 1.11
Structural analysis of human and macaque mAbs 2909 and 2.5B: implications for the configuration of the quaternary neutralizing epitope of HIV-1 gp120. Structure (2011) 1.10
HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies. AIDS Res Hum Retroviruses (2011) 1.07
Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry (2005) 1.05
Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions. AIDS (2002) 1.04
Facilitating outpatient treatment entry following detoxification for injection drug use: a multisite test of three interventions. Psychol Addict Behav (2009) 1.03
Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines. AIDS Res Hum Retroviruses (2010) 1.02
Seasonal variations in the initiation of smoking among adolescents. Nicotine Tob Res (2006) 1.02
Symbiosis as a source of selectable epigenetic variation: taking the heat for the big guy. Philos Trans R Soc Lond B Biol Sci (2010) 1.00
Acute knee dislocation: an evidence based approach to the management of the multiligament injured knee. Injury (2010) 0.99
Implementation of a Smoking Cessation Treatment Study at Substance Abuse Rehabilitation Programs: Smoking Behavior and Treatment Feasibility Across Varied Community-based Outpatient Programs. J Addict Med (2007) 0.99
Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors. Genes Chromosomes Cancer (2008) 0.99
A new system for severity scoring of facial fractures: development and validation. J Craniofac Surg (2010) 0.99
Reducing HIV-related risk behaviors among injection drug users in residential detoxification. AIDS Behav (2011) 0.99
Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation. Eur J Immunol (2005) 0.99
Chronic fetal exposure to Ureaplasma parvum suppresses innate immune responses in sheep. J Immunol (2011) 0.97
A novel method for KIR-ligand typing by pyrosequencing to predict NK cell alloreactivity. Clin Immunol (2007) 0.96
Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients. Psychiatr Serv (2004) 0.96
Keeping all children healthy: challenges to leading an active lifestyle for preschool children qualifying for at-risk programs. Fam Community Health (2005) 0.93
Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes. J Virol (2011) 0.93
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2. Bioorg Med Chem (2008) 0.91
Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000. J Am Acad Child Adolesc Psychiatry (2003) 0.91
Small molecule colorimetric probes for specific detection of human arylamine N-acetyltransferase 1, a potential breast cancer biomarker. J Am Chem Soc (2010) 0.91
Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines. Int J Cancer (2006) 0.90
Cattle MHC nomenclature: is it possible to assign sequences to discrete class I genes? Immunogenetics (2012) 0.90
The RAISE early treatment program for first-episode psychosis: background, rationale, and study design. J Clin Psychiatry (2015) 0.90
Comparison of functional outcomes in low- and high-grade astrocytoma rehabilitation inpatients. Am J Phys Med Rehabil (2010) 0.90
Folding pathway of apo-metallothionein induced by Zn2+, Cd2+ and Co2+. J Inorg Biochem (2002) 0.86
Dose optimization in cardiac x-ray imaging. Med Phys (2013) 0.85
What Influences Participation in QI? A Randomized Trial of Addiction Treatment Organizations. J Healthc Qual (2015) 0.85
Theory-based development and testing of an adolescent tobacco-use awareness program. Am J Health Behav (2002) 0.84
Increased plasma levels of soluble vascular endothelial growth factor receptor 1 (sFlt-1) in women by moderate exercise and increased plasma levels of vascular endothelial growth factor in overweight/obese women. Eur J Cancer Prev (2013) 0.84
Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase II. Bioorg Med Chem Lett (2003) 0.84
A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence. Addiction (2005) 0.83
Seroprevalence of simian immunodeficiency virus in wild and captive born Sykes' monkeys (Cercopithecus mitis) in Kenya. Retrovirology (2004) 0.82
Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding. J Mol Med (Berl) (2005) 0.82
BOUNCE: an exploratory healthy lifestyle summer intervention for girls. Am J Health Behav (2009) 0.82
Differences in evaluations of a tobacco awareness and cessation program by adolescents in four stages of change. Addict Behav (2003) 0.81
Return to primary service among bone marrow transplant rehabilitation inpatients: an index for predicting outcomes. Arch Phys Med Rehabil (2012) 0.81
Comparison of third toe joint cartilage thickness to that of the finger proximal interphalangeal (PIP) joint to determine suitability for transplantation in PIP joint reconstruction. J Hand Surg Am (2011) 0.81
Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry (2003) 0.81
Economics. Foundations of societal inequality. Science (2009) 0.81
Comparing high and low acculturated mothers and physical activity in Hispanic children. J Phys Act Health (2011) 0.81
A placebo controlled, double-blind study of mecamylamine treatment for cocaine dependence in patients enrolled in an opiate replacement program. Subst Abus (2005) 0.81
Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans. Br J Pharmacol (2012) 0.81
Does enteric-coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin? Interact Cardiovasc Thorac Surg (2007) 0.80
Elevation of WNT5A expression in polyp formation in Lkb1+/- mice and Peutz-Jeghers syndrome. J Pathol (2011) 0.80
Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: exploring predictors of outcome as clues toward treatment improvement. Am J Drug Alcohol Abuse (2011) 0.80
Two-bundle, four-tunnel anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc (2005) 0.80
Combined preoperative angiography with transient uterine artery embolization makes laparoscopic surgery for massive myomatous uteri a reasonable option: case reports. J Minim Invasive Gynecol (2012) 0.79
Cystically degenerated leiomyoma of the rectosigmoid managed laparoscopically at 13 weeks of gestation. J Minim Invasive Gynecol (2012) 0.79
Automated compound verification using 2D-NMR HSQC data in an open-access environment. Magn Reson Chem (2009) 0.79
Amido-modified polylactide for potential tissue engineering applications. J Biomater Sci Polym Ed (2004) 0.79
Perfluorocyclobutyl-linked hexa-peri-hexabenzocoronene networks. J Am Chem Soc (2004) 0.78
Synthesis and electronic factors in thermal cyclodimerization of functionalized aromatic trifluorovinyl ethers. J Am Chem Soc (2006) 0.78
Frequency and reasons for return to acute care in patients with leukemia undergoing inpatient rehabilitation: a preliminary report. Am J Phys Med Rehabil (2013) 0.78
Summer and follow-up interventions to affect adiposity with mothers and daughters. Am J Prev Med (2013) 0.78
Falling up the stairs: the equivalent of 'bashing it with a bible' for an ACL ganglion cyst of the knee. BMJ Case Rep (2012) 0.78
Importance of tobacco cessation services at higher education public institutions in Texas. J Drug Educ (2004) 0.77